'This attack scenario underscores the need to harden the synthetic DNA supply chain with protections against cyber-biological threats,' said a leading Israeli cyber expert.
Israel’s 2bPrecise takes genetic data to help determine best treatment for individuals; FDA approves HemoScreen portable blood test to sell in US, and more.